CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $4.52 ($113,045)
- 4 Open-market sale Chief Financial Officer sold 8,000 shares at $4.74 ($37,914)
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- 4 Other acquisition Chief Financial Officer acquired 5,362 shares (other)
- 4 Other acquisition Sr. Vice President and COO acquired 1,097 shares (other)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
Page 17 of 24 · 469 filings